SUMMARY -Glioblastoma multiforme represents one of the most common brain cancers with
Introduction
Gliomas are the most common type of primary brain tumours. Nearly two thirds of gliomas are highly malignant lesions with fast progression and poor prognosis. Despite recent advances, the two-year survival for glioblastoma with optimal therapy is less than 30% 1 . Recent studies have demonstrated the existence of a small fraction of glioma cells endowed with features of primitive neural progenitor cells and a tumour-initiating function 2 . In general, this fraction is characterized to form neurospheres, expressing CD133 gene and other genes characteristic of neural stem cells and possessing the self-renewal potential 3 . Neural cancer stem cells (NCSC) derived from glioblastoma (GBM) are able to recapitulate original polyclonal tumours when xenografted to nude mice 4 . They are chemoresistant and radioresistant and therefore responsible for tumour progression and recurrence after conventional glioblastoma therapy. Our study focused on the distribution of NCSC inside GBMs of eight patients who underwent surgery in an operative room equipped with a 1.5 T scanner.
Materials and Methods

NCSC isolation
A pre-operative cerebral MRI (Figure 1 ) identified the centre (C), periphery (P) and marginal zone (MZ) of the tumour obtained during surgery. Post-operative cerebral MRI confirmed the removal of tumour specimens in C, P and MZ. Tumour samples were dissociated and transferred into 15 ml of CSF containing 1.3 mg/ml trypsin, 0.67 mg/ml hyarulonidase, and 0.2 mg/ml kynurenic acid and incubated under continuous oxygenation and stirring for 90 min at 32-34°C. Tissues were then rinsed in aCSF for 10 min, transferred to Dulbecco's modified essential medium (DMEM)/F12 containing 0.7 mg/ml ovomucoid, and carefully triturated with a fire-polished Pasteur pipette. Primary cells were plated in 25 cm 2 tissue culture flasks plated at clonal density (2500-5000 cells/cm 2 ) in DMEM/F12 medium containing 20 ng/mL of both epidermal (EGF) and fibroblast (FGF) growth factors. As reference cell lines, normal human foetal neural stem cells and the glioblastoma cell line U87MG were used in all of the assays. Two weeks later, the cultures were harvested, mechanically dissociated and replated under the same conditions. After performing this procedure twice to eliminate short-term dividing precursors, bulk cultures were generated by passing the cells at a higher density (10 4 cells/cm 2 ) in the same growth medium every ten days. To detect neural precursors within human brain tumours, cells from post-surgery specimens of glioblastoma multiforme tumours were plated at clonal density in serum-free medium containing EGF and FGF2. This provides a stringent low-density system (<5 × 10 3 cells/cm 2 ), which selects away differentiated/differentiating cells in primary CNS cultures, leaving neural stem cells free to proliferate and expand exponentially. Twenty to 40 days after plating, phase-bright clones resembling the classical neurospheres formed in vitro by normal neural stem cells were detected in all of the cultures established from C, P, and MZ of high-grade glioblastoma multiforme tumours. To assess for multipotency, cells were plated at a density of 2.5 × 10 4 cells/ cm 2 onto Matrigel-coated glass coverslips (12 mm diameter) in the presence of leukaemia inhibitory factor (10 ng/mL) for seven to ten days 5 .
Immunocytochemistry
The cell composition was analyzed by means of immunostaining with lineage-specific antibodies.
The cells were fixed for 20 min in 4% paraformaldehyde in phosphate-buffered saline (PBS), pH 7.4, and then washed and incubated with PBS/0.1% Triton-X containing 10% normal goat serum and the appropriate antibody mixture for 90 min at 37°C. The primary antibodies were rabbit anti-glial fibrillary acidic protein (ready to use; Incstar Corporation; Stillwater, MN, USA), mouse anti-ß-tubulinIII (1:1000; Sigma) and anti-galactocerebroside (1:300; Sigma). After some washing, the cul- tures were incubated for 45 min at room temperature with secondary fluorescein isothiocyanate-or rhodamine isothiocyanate-conjugated goat antimouse or antirabbit IgG antibodies (1:100; Boehringer Mannheim), washed, incubated with 4', 6-diamidino2-phenylinole dihydrochloride (1 mg/ml in methanol, 15 min at 37°C, and finally mounted using Fluorsave TM and viewed under a Zeiss Axiophot-2 microscope 6 . 
CD133 expression in NCSC
To investigate whether NCSC express CD133 we applied flow cytometry analysis and using an SHSY neuroblastoma cell line as positive control and human lymphocytes as negative control.
Results
Neurospheres formed in vitro by normal neural stem cells were detected in all of the cultures established from C, P, and MZ of highgrade glioblastoma multiforme tumours (Figure 2) . C, P, and MZ cancer cells proliferated differently: at first passage MZ cells proliferated more than C and P cells; at the second passage C, P, and MZ cells did not proliferate and at the third passage only C and P cells proliferated and the proliferation rate became exponentially higher for C cells (Figure 3 ). Only MZ cells had the capacity to generate neurons, oligodendrocytes and astrocytes (Figure 4) . MZ cells may be pseudoneural cancer stem cells. Therefore, we studied CD133 expression in C, P and MZ. CD133 was expressed heterogeneously in uniformly undifferentiated human neural stem (NS) cell cultures. The recent finding that a significant fraction of clonogenic neural stem cells lack the established marker CD133 and that some of these cells may be dormant or slow-cycling has implications for approaches to identify and isolate neural stem cells and brain cancer stem cells. Recent data also suggest that CD133 may be specifically down-regulated during G0/G1, and this should be considered when this marker is used to identify and isolate other tissue and cancer stem cells. In our study, P cells expressed the highest percentage of CD133 ( Figure 5 ).
Discussion and Conclusion
Glioblastoma multiforme represents one of the most common brain cancers and may either develop from lower grade astrocytic tumours (secondary or progressive glioblastoma multiforme) or may arise very rapidly de novo. In both cases, neither chemotherapy nor radiotherapy has been effective in managing these cancers 7 . Recent studies have demonstrated the existence of a small fraction of glioma cells endowed with features of primitive neural progenitor cells and a tumour-initiating function. The initial study by Ignatova et al. 8 described the isolation of neurosphere-forming, bipotent (neuronal/astroglial) precursors from glioblastoma multiforme tumours and was subsequently extended by Singh et al. 9 , who also demonstrated that bipotent progenitors from CNS tumours (mostly medulloblastomas) displayed short-term self-renewal (three passages in culture). Galli et al. 2 demonstrated the isolation and identification of human glioblastoma multiforme cells, which possess all of the defining features of somatic stem cells, including ex vivo multipotency (i.e., the potential to generate simultaneously cells displaying antigenic reactivity for neuronal, astroglial, and oligodendroglial markers in culture and the ability to establish and expand glioblastoma multiforme-like tumours).
Beier et al. 3 detected CD133 expression in a relatively small subpopulation of cells in brain tumours. When these CD133+ cells were isolated, they were able to proliferate, form clonal neurospheres, and produce new tumours after serial transplantation. CD133 positive cells are therefore considered candidate cancer stem cells that maintain tumours. No study has analysed the distribution of NCSC inside GBMs. Our study was carried out in an operating theatre equipped with a 1.5 T scanner and a neuronavigator. This allowed us to identify three GBM zones (C, P, MZ) and we obtained tumour specimens from these zones; post-operative cerebral MRI confirmed the removal of specimens in the selected point. We have shown that C, P and Mz cells formed neurospheres; at the third passage MZ cells did not proliferate and differentiated. P and C cells did not differentiate and C cells expressed the highest percentage of CD133; P cells could be the real NCSC. The study presents some limits: few cases were studied and it remains unclear whether tumour neural stem cells in glioblastoma multiforme derive from the transformation of normal human neural stem cells or whether their presence therein reflects the result of the transformation and de-differentiation of a more mature brain cell, which gave rise to otherwise silent/ latent stem cell properties.
